News
ATNFW
0.0088
-11.92%
-0.0012
Weekly Report: what happened at ATNFW last week (1111-1115)?
Weekly Report · 5d ago
180 LIFE SCIENCES CORP FILES FOR OFFERING OF UP TO 1.9 MLN SHARES BY THE SELLING STOCKHOLDER - SEC FILING
Reuters · 11/15 21:17
Weekly Report: what happened at ATNFW last week (1104-1108)?
Weekly Report · 11/11 11:44
Weekly Report: what happened at ATNFW last week (1028-1101)?
Weekly Report · 11/04 11:41
180 Life Sciences Corp: Current report
Press release · 10/30 00:13
Weekly Report: what happened at ATNFW last week (1021-1025)?
Weekly Report · 10/28 11:32
ELRAY RESOURCES ANNOUNCES STRATEGIC SALE OF CRYPTO IGAMING TECHNOLOGY
Reuters · 10/25 13:00
Weekly Report: what happened at ATNFW last week (1014-1018)?
Weekly Report · 10/21 11:28
BUZZ-U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
Reuters · 10/17 18:05
BUZZ-U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy
Reuters · 10/17 13:21
BUZZ-U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics
Reuters · 10/16 15:56
BUZZ-U.S. STOCKS ON THE MOVE-United Airlines, Morgan Stanley, Autodesk
Reuters · 10/16 13:22
180 LIFE SCIENCES: EXPECTS TO LAUNCH PLANNED B2C CASINO OPERATIONS IN ESTABLISHED & HIGH-GROWTH MARKETS WHERE IGAMING IS GAINING TRACTION
Reuters · 10/16 12:07
180 LIFE SCIENCES: CURRENTLY HAVE LIMITED CASH ON HAND, EXPECT TO NEED TO RAISE FUNDING THROUGH DEBT OR EQUITY FUNDING IN FUTURE
Reuters · 10/16 12:07
180 LIFE SCIENCES: TARGETING HAVING FIRST ONLINE CASINO FULLY OPERATIONAL & OPTIMIZED FOR GROWTH BY END OF Q1 2025
Reuters · 10/16 12:07
Weekly Report: what happened at ATNFW last week (1007-1011)?
Weekly Report · 10/14 12:00
180 Life Sciences Corp: Current report
Press release · 10/09 14:07
180 LIFE SCIENCES CORP - REGAINS COMPLIANCE WITH NASDAQ
Reuters · 10/09 12:32
Weekly Report: what happened at ATNFW last week (0930-1004)?
Weekly Report · 10/07 11:48
More
Webull provides a variety of real-time ATNFW stock news. You can receive the latest news about 180 Life Sciences Corp through multiple platforms. This information may help you make smarter investment decisions.
About ATNFW
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. The Company is primary focused on program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). The Company has three product development platforms: Anti-TNF platform, SCAs platform and a7nAChR platform. Anti-TNF platform is focused on fibrosis and anti-tumor necrosis factor (anti-TNF). SCAs platform is focused on drugs which are synthetic cannabidiol (CBD) or cannabigerol (CBG) analogues (SCAs). a7nAChR platform is focused on alpha 7 nicotinic acetylcholine receptor (a7nAChR). It is conducting clinical trials only for certain indications under the anti-TNF platform. The Company is undertaking preclinical research and development activities for the SCA platform.